NFH
FOLD

NEXT Financial Holdings’s Amicus Therapeutics FOLD Stock Holding History

NEXT Financial Holdings’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$36K Buy
+2,625
New +$32.1K 0.01% 810

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NEXT Financial Holdings's FOLD Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Amicus Therapeutics (FOLD) in Q1 2019: 2,625 shares worth $36K. The stake represents 0.01% of the portfolio and ranks #810 among its holdings.

205 funds tracked by Wall St. Rank hold FOLD as of Q1 2019.

  • NEXT Financial Holdings held 2,625 shares of Amicus Therapeutics worth $36K as of Q1 2019.
  • Amicus Therapeutics was a new NEXT Financial Holdings position in Q1 2019.
  • Amicus Therapeutics made up 0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #810 holding.
  • 205 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.